🇺🇸 FDA
Pipeline program

Recombinant 14-Valent Human Papillomavirus Vaccine(Insect Cell)

SCT1000-03

Phase 3 mab active

Quick answer

Recombinant 14-Valent Human Papillomavirus Vaccine(Insect Cell) for HPV InfectioN is a Phase 3 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
HPV InfectioN
Phase
Phase 3
Modality
mab
Status
active

Clinical trials